Recognition of antigenic epitopes in lipopolysaccharide and protein from Actinobacillus actinomycetemcomitans by serum antibodies in untreated rapidly progressive periodontitis patients

Oral Microbiology and Immunology

Volumn 12, Issue 1, 1997, Pages 11-19

  Ou, J G ^a   Bainbridge, B ^c,d   Gu, K ^a,c   Sims, T J ^c   Whitney, C W ^a   Darveau, R P ^a,d   Chen, H A ^a   Houston, L S ^a   Page, R C ^a,b,c  

^a School of Dentistry University   (United States)

^b Seattle Children's Hospital   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d BRISTOL MYERS SQUIBB   (United States)

Author keywords

Antibody; Antigen epitope Actinobacillus actinornycetemcornitans; ELISA; Lipopolysaccharide; Periodontal disease; Protein

Indexed keywords

EID: 0031076344     PISSN: 09020055     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-302X.1997.tb00361.x     Document Type: Article

References (48)

1. Appelmelk BJ, Su D, Marian A, Verwiej-van Vught JJ, Thijs BG, MacLaren DM. Polymyxin B-horseradish peroxidase conjugates as tools in endotoxin research. Anal Biochem 1992: 207: 311-316.
2. Brondz I, Olsen I. Differentiation between Actinobacillus actinomycetemcomitans and Haemophilus aphrophilus based on carbohydrate and lipopolysaccharide. J Chromatogr 1984: 310: 261-272.
3. Brown JR, Shockley P. In: Jost PC, Griffiths OH, ed. Lipid-protein interaction. vol. I. New York: John Wiley & Sons, 1982: 42-49.
4. Bryn K, Jantzen E. Analysis of lipopolysaccharide by methanolysis, trifluoroacetylation, and gas chromatography on a fused silica capillary column. J Chromatogr 1982: 240: 405-413.
5. Butler JE. The amplified ELISA (a-ELISA): immunochemistry and applications. In: Kemeny DM, Challacomb SJ, ed. ELISA and other solid phase immunoassays. Chichester: John Wiley & Sons, 1988: 107-133.
6. Califano JV, Schenkein HA, Tew JG. Immunodominant antigen of Actinobacillus actinomycetemcomitans Y4 in high-responder patients. Infect Immun 1989: 57: 1582-1589.
7. Chen H, Johnson BD, Sims TJ et al. Humoral response to Porphyromonas gingivalis before and following therapy in rapidly progressive periodontitis patients. J Periodontol 1991: 62: 781-791.
8. DiPadova FE, Brade H, Barclay GR et al. A broadly cross-protective monoclonal antibody binding to Escherichia call and Salmonella lipopolysaccharides. Infect Immun 1993: 61: 3863-3872.
9. Doty SL, Lopatin DE, Syed SA, Smith FN. Humoral immune response to oral microorganisms in periodontitis. Infect Immun 1982: 37: 99-505.
10. Dubois M, Gilles KA, Hamilton JK, Rebers PA, Smith F. Colorimetric for determination of sugars and related substances. Anal Biochem 1956: 28: 350-356.
11. Erich T, Schellekens J, Bouter A, Van Kranen J, Bronwer E, Verhoef J. Binding characteristics and cross-reactivity of three different antilipid A monoclonal antibodies. J Immunol 1989: 143: 4053-4060.
12. Field SK, Morrison DC. An anti-idiotype antibody which mimics the innercore region of lipopolysaccharide protects mice against a lethal challenge with endotoxin. Infect Immun 1964: 62: 3994-3999.
13. Gatt R, Berman ER. A rapid procedure for the estimation of amino sugars on a microscale. Anal Biochem 1966: 15: 167-171.
14. Genco RJ, Zambon JJ, Murray PA. Serum and gingival fluid antibodies as adjuncts in the diagnosis of Actinobacillus actinomycetemcomitans-associated periodontal disease. J Periodontol 1985: 56(II suppl): 41-50.
15. Huemann D, Baumgartner JD, Jacot-Guilarmod H, Glauser MP. Antibodies to core lipopolysaccharide determinants: absence of cross-reactivity with heterologous lipopolysaccharides. J Infect Dis 1991: 163: 762-768.
16. Kiley P, Holt SC. Characterization of the lipopolysaccharide from Actinobacillus actinomycetemcomitans Y4 and N-27. Infect Immun 1980: 30: 862-873.
17. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurements with the folin phenol reagent. J Biol Chem 1951: 193: 265-275.
18. Mascelli MA, Frederick B, Ely T et al. Reactivity of the human antiendotoxin immunoglobulin M monoclonal antibody HA-IA with lipopolysaccharides from rough and smooth gram-negative organisms. Infect Immun 1993: 61: 1756-1763.
19. Masoud H, Weintraub ST, Wang R, Cotter R, Holt SC. Investigation of the structure of lipid A from Actinobacillus actinomycetemcomitans strain Y4 and human clinical isolate PO 1021-7. Eur J Biochem 1991: 200: 775-781.
20. Moore WEC. Microbiology of periodontal disease. J Periodont Res 1987: 22: 335-341.
21. Morrison DC, Jacobs DM. Binding of polymyxin B to lipid A portion of bacterial lipopolysaccharides. Immunochemistry 1976: 13: 813-818.
22. Naito Y, Okada K, Takazoe I. Immunoglobulin G response to subgingival gram-negative bacteria in human subjects. Infect Immun 1984: 45: 47-51.
23. Ndubisi AN, Lind SM, Lindberg AA. The disaccharide L-alpha-o-heptose 1-7-L-alpha-D-heptose 1- of the inner core domain of Salmonella lipopolysaccharide is accessible to antibody and is the epitope of a broadly reactive monoclonal antibody. J Immunol 1992: 149: 2722-2728.
24. Nishimura F, Nagai A, Kurimoto K et al. A family study of a mother and daughter with increased susceptibility to early-on-set periodontitis: microbiological, immunological, host defensive, and genetic analyses. J Periodontol 1990: 61: 755-762.
25. Page RC, Altman LC, Ebersole JL et al. Rapidly progressive periodontitis - a distinct clinical condition. J Periodontol 1983: 54: 197-209.
26. Page RC, Sims TJ, Engel LD et al. The immunodominant outer membrane antigen of Actinobacillus actinomycetemcomitans is located in the serotype-specific high-molecular-mass carbohydrate moiety of lipopolysaccharide. Infect Immun 1991: 59: 3451-3462.
27. Parent JB, Gazzano-Santoro H, Wood DM et al. Reactivity of monoclonal antibody E5 with endotoxin. II. Binding to short- and long-chain smooth lipopolysaccharides. Circ Shock 1992: 38: 63-73.
28. Raetz CRH. Biochemistry of endotoxin. Annu Rev Biochem 1990: 59: 29-170.
29. Schei O, Waerhaug J, Lovdal A, Arno A. Alveolar bone loss as related to oral hygiene and age. J Periodontol 1959: 30: 7-16.
30. Scott BB, Barclay GR. Endotoxin-polymyxin complex in an improved enzyme-linked immunosorbent assay for IgG antibodies in blood donor sera to gramnegative endotoxin core glycolipids. Vox Sang 1987: 52: 272-280.
31. Sims TJ, Moncla BJ, Darveau RP, Page RC. Antigens of Actinobacillus actinomycetemcomitans recognized by patients with juvenile periodontitis and periodontally normal subjects. Infect Immun 1991: 59: 913-924.
32. Sims TJ, Moncla BJ, Page RC. Serum antibody responses to antigens of oral gram-negative bacteria in cats with plasma cell gingivitis-pharyngitis. J Dent Res 1990: 69: 877-882.
33. Sjöström K, Darveau R, Page RC, Whitney C, Engel D. Opsonic antibody activity against Actinobacillus actinomycetemcomitans in patients with rapidly progressive periodontitis. Infect Immun 1992: 60: 4819-4825.
34. Sjöström K, Ou J, Whitney C et al. Effect of treatment on titer, function, and antigen recognition of serum antibodies to Actinobacillus actinomycetemcomitans in patients with rapidly progressive periodontitis. Infect Immun (in press).
35. Slots J, Feik D, Rams TE. Actinobacillus actinomycetemcomitans and Bacteroides intermedius in human periodontitis: age relationship and mutual association. J Clin Periodontol 1990: 17: 659-662.
36. Slots J, Reynolds HS, Genco RJ. Actinobacillus actinomycetemcomitans in human periodontal disease: a cross-sectional microbiological investigation. Infect Immun 1980: 29: 1013-1020.
37. Slots J, Zambon JJ, Rosling BG, Reynolds HS, Christersson LA, Genco RJ. Actinobacillus actinomycetemcomitans in human periodontal disease: association, serology, leukotoxicity, and treatment. J Periodont Res 1982: 17: 447-455.
38. Underwood K, Sjöström K, Darveau R et al. Serum antibody opsonic activity against Actinobacillus actinomycetemcomitans in human periodontal diseases. J Infect Dis 1993: 168: 1436-1443.
39. Van Winkelhoff AJ, Rodenburg JP, Goen'e RJ, Abbas F, Winkel EG, de Graaff J. Metronidazolc plus amoxycillin in the treatment of Actinobacillus actinomycetemcomitans associated periodontitis. J Clin Periodontol 1989: 16: 128-131.
40. Vasel D, Sims TJ, Bainbridge B, Houston L, Darveau R, Page RC. Shared antigens of Porphyromonas gingivalis and Bacteroides forsythus. Oral Microbiol Immunol 1996: 11: 226-235.
41. Vincent JW, Suzaki JB, Falkler WA Jr, Cornett WC. Reaction of human sera from juvenile periodontitis, rapidly progressive periodontitis, and adult periodontitis patients with selected periodontopathogens. J Periodontol 1985: 56: 464-469.
42. Westphal O, Jann K. Bacterial lipopolysaccharides: extraction with phenolwater and further applications of the procedure. Methods Carbohydr Chem 1965: 5: 83-91.
43. Whitney C, Ant J, Moncla B, Johnson B, Page RC, Engel D. Serum immunoglobulin G antibody to Porphyromonas ginglvalis in rapidly progressive periodontitis: titer, avidity, and subclass distribution. Infect Immun 1992: 60: 2194-2200.
44. Wilson ME, Schifferle RE. Evidence that the serotype b antigenic determinant of Actinobacillus actinomycetemcomitans Y4 resides in the polysaccharide moiety of lipopolysaccharide. Infect Immun 1991: 59: 1544-1551.
45. Zafiropoulos GG, Flores de Jacoby L, D. Hungerer KD, Nisengard RJ. Humoral antibody responses in periodontal disease. J Periodontol 1992: 63: 80-86.
46. Zambon JJ. Actinobacillus actinomycetemcomitans in human periodontal disease. J Clin Periodontol 1985: 12: 1-20.
47. Zambon J, Slots J, Genco R. Serology of oral Actinobacillus actinomycetemcomitans and serotype distribution in human periodontal disease. Infect Immun 1983: 41: 19-27.
48. Zambon JJ, Umemoto T, DeNardin E, Nakazawa F, Christersson LA, Genco R. Actinobacillus actinomycetemcomitans in the pathogenesis of human periodontal disease. Adv Dent Res 1988: 2: 269-274.